Literature DB >> 5105682

Microbiological study of copiamycin.

K Seiga, K Yamaji.   

Abstract

Copiamycin, an antibiotic agent, has shown in vitro activity against Candida albicans, Torulopsis glabrata, and Trichomonas vaginalis. Local administration of copiamycin to mice inoculated intraperitoneally with protozoa reduced the per cent of infection as measured by decreased abscess formation. This antibiotic has had little effect on the glucose oxidation by protozoa. Its action on anaerobic glucose metabolism in these organisms was equal to that of aminitrozole and azalomycin F. From these results we conclude that copiamycin is an effective antifungal and antitrichomonal agent equivalent in activity to azalomycin F.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5105682      PMCID: PMC377328          DOI: 10.1128/am.21.6.986-989.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  1 in total

1.  COPIAMYCIN, A NEW ANTIFUNGAL ANTIBIOTIC DERIVED FROM S. HYGROSCOPICUS VAR. CHRYSTALLOGENES.

Authors:  T ARAI; S KURODA; H OHARA; Y KATOH; H KAJI
Journal:  J Antibiot (Tokyo)       Date:  1965-03       Impact factor: 2.649

  1 in total
  2 in total

1.  Actinomycetes from the Red Sea Sponge Coscinoderma mathewsi: Isolation, Diversity, and Potential for Bioactive Compounds Discovery.

Authors:  Yara I Shamikh; Aliaa A El Shamy; Yasser Gaber; Usama Ramadan Abdelmohsen; Hashem A Madkour; Hannes Horn; Hossam M Hassan; Abeer H Elmaidomy; Dalal Hussien M Alkhalifah; Wael N Hozzein
Journal:  Microorganisms       Date:  2020-05-23

Review 2.  Guanidine-Containing Polyhydroxyl Macrolides: Chemistry, Biology, and Structure-Activity Relationship.

Authors:  Xiaoyuan Song; Ganjun Yuan; Peibo Li; Sheng Cao
Journal:  Molecules       Date:  2019-10-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.